2016
Opened business in the U.S.
DRL is a clinical research organization providing pharma and biotech with human biospecimens, primary cell lines, 3D tumor models, and GLP-aligned preclinical services. Founded in 2016, we operate laboratories in the US and Europe. By controlling our own facilities, we maintain full quality oversight, competitive pricing, and faster turnaround.
Highly accomplished and passionate leader with 20 years of experience. Expertise in expanding market share, establishing international distribution networks, and driving significant revenue growth.Experience as Business Unit Manager at Merck and Solvay Pharmaceuticals (owned by Abbott), as well as experience at Boehringer Ingelheim.
Research scientist with 10+ years of experience in academia and industry, specializing in signaling aberrations in tumors and their microenvironment. Certified in GCP, GLP, and drug development. 15 first-author publications in top-tier scientific journals, and established partnerships with academia, biotech, and the pharmaceutical industry.
Business executive with 15+ years of experience leading and executing new growth opportunities in biotech and tech, specializing in customer success, operations, and partnership. Most recently VP of Innovation & Strategy at a listed diagnostics company in the US. MBA from the Wharton School (UPenn) and BA in Economics from Stanford with Distinction.
